Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Victor I. Seledtsov & Alexei von Delwig. (2021) Clinically feasible and prospective immunotherapeutic interventions in multidirectional comprehensive treatment of cancer. Expert Opinion on Biological Therapy 21:3, pages 323-342.
Read now
Read now
Victor Ivanovich Seledtsov & Alexei A. von Delwig. (2020) Immune memory limits human longevity: the role of memory СD4+ T cells in age-related immune abnormalities. Expert Review of Vaccines 19:3, pages 209-215.
Read now
Read now
Victor I. Seledtsov & Galina V. Seledtsova. (2019) Total threshold cytotoxicity of therapeutic antibodies for selective destruction of pathogenic memory T cells: implications for immunotherapy of autoimmune and allergenic disorders. Expert Review of Clinical Immunology 15:7, pages 701-706.
Read now
Read now
Jingxin Zhang, Qiqi Liu, Lili Qiao, Pingping Hu, Guodong Deng, Ning Liang, Jian Xie, Hui Luo & Jiandong Zhang. (2017) Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer. OncoTargets and Therapy 10, pages 2227-2237.
Read now
Read now
Articles from other publishers (52)
Hirotaka Miyashita, Razelle Kurzrock, Nicholas J. Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary Nesline, Sean T. Glenn, Jeffrey M. Conroy, Paul DePietro, Eitan Rubin, Jason K. Sicklick & Shumei Kato. (2023) T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy. npj Genomic Medicine 8:1.
Crossref
Crossref
Yujian Teng, Licheng Xu, Wenjing Li, Pengyan Liu, Linli Tian & Ming Liu. (2023) Targeting reactive oxygen species and fat acid oxidation for the modulation of tumor-associated macrophages: a narrative review. Frontiers in Immunology 14.
Crossref
Crossref
Victor Ivanovich Seledtsov, Adas Darinskas, Alexei Von Delwig & Galina Victorovna Seledtsova. (2023) Inflammation Control and Immunotherapeutic Strategies in Comprehensive Cancer Treatment. Metabolites 13:1, pages 123.
Crossref
Crossref
Kun Yu, Chengxin Yu, Liping Jiao, Kun Miao, Li Ni, Xiaoquan Rao, Ling Zhou & Chunxia Zhao. (2022) The Function and Therapeutic Implications of TNF Signaling in MDSCs. Biomolecules 12:11, pages 1627.
Crossref
Crossref
Cheng-Liang Kuo, Ananth Ponneri Babuharisankar, Ying-Chen Lin, Hui-Wen Lien, Yu Kang Lo, Han-Yu Chou, Vidhya Tangeda, Li-Chun Cheng, An Ning Cheng & Alan Yueh-Luen Lee. (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?. Journal of Biomedical Science 29:1.
Crossref
Crossref
Xinqiang Gan, Ruiji Liu, Hong Cheng, Weipu Mao, Ninghan Feng & Ming Chen. (2022) ASNS can predict the poor prognosis of clear cell renal cell carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Donghoon Kang & In-Ho Kim. (2022) Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer. Biomedicines 10:6, pages 1376.
Crossref
Crossref
V. I. Seledtsov, G. V. Seledtsova, A. B. Dorzhieva & I. P. Ivanova. (2022) Immunotherapy in the complex treatment of tumor diseases. Siberian journal of oncology 21:2, pages 118-129.
Crossref
Crossref
Siyi Li, Jinan Wang, Yan Yan, Zekun Zhang, Wei Gong & Shaoping Nie. (2022) Clinical Characterization and Possible Pathological Mechanism of Acute Myocardial Injury in COVID-19. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Rong Yang, Shanshan Zhou & Qibing Zhou. (2022) In vitro naphthylquinoxaline thymidine conjugate and UVA treated cancer cells are effective therapeutic vaccines for tumors in vivo with CpG as the adjuvant. Journal of Advanced Research 35, pages 259-266.
Crossref
Crossref
Anugya Sengar, Manisha Sengar, Zoya Mann & Pawan Kumar Raghav. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
2599
2614
.
Anugya Sengar, Manisha Sengar, Zoya Mann & Pawan Kumar Raghav. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
16
.
A. B. Dorzhieva, T. S. Khabalova, Yu. E. Androsova, E. A. Kaschenko, I. P. Ivanova & G. V. Seledtsova. (2021) EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS. Medical Immunology (Russia) 23:4, pages 665-670.
Crossref
Crossref
Ornella Franzese, Francesco Torino, Elisa Giannetti, Giorgia Cioccoloni, Angelo Aquino, Isabella Faraoni, Maria Pia Fuggetta, Liana De Vecchis, Anna Giuliani, Bernd Kaina & Enzo Bonmassar. (2021) Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?. International Journal of Molecular Sciences 22:19, pages 10672.
Crossref
Crossref
Dmitry Aminin & Yun‐Ming Wang. (2021) Macrophages as a “weapon” in anticancer cellular immunotherapy. The Kaohsiung Journal of Medical Sciences 37:9, pages 749-758.
Crossref
Crossref
Inken Salewski, Julia Henne, Leonie Engster, Bjoern Schneider, Heiko Lemcke, Anna Skorska, Peggy Berlin, Larissa Henze, Christian Junghanss & Claudia Maletzki. (2021) Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors. International Journal of Molecular Sciences 22:11, pages 5990.
Crossref
Crossref
Yongchang Lai, Fucai Tang, Yapeng Huang, Chengwu He, Chiheng Chen, Jiquan Zhao, Wenqi Wu & Zhaohui He. (2020) The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy. Journal of Cellular Physiology 236:3, pages 1616-1627.
Crossref
Crossref
Faisal Raza, Hajra Zafar, Shulei Zhang, Zul Kamal, Jing Su, Wei‐En Yuan & Qiu Mingfeng. (2021) Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy. Advanced Healthcare Materials 10:6, pages 2002081.
Crossref
Crossref
Gyaviira Nkurunungi, Ludoviko Zirimenya, Jacent Nassuuna, Agnes Natukunda, Prossy N Kabuubi, Emmanuel Niwagaba, Gloria Oduru, Grace Kabami, Rebecca Amongin, Alex Mutebe, Milly Namutebi, Christopher Zziwa, Susan Amongi, Caroline Ninsiima, Caroline Onen, Florence Akello, Moses Sewankambo, Samuel Kiwanuka, Robert Kizindo, James Kaweesa, Stephen Cose, Emily Webb & Alison M Elliott. (2021) Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the ‘POPulation differences in VACcine responses’ (POPVAC) programme. BMJ Open 11:2, pages e040426.
Crossref
Crossref
Sundareswaran loganathan, Maheshkumar Kuppusamy, Wankupar Wankhar, Krishna Rao Gurugubelli, Vidyashree Hodagatta Mahadevappa, Lhakit Lepcha & Arbind kumar Choudhary. (2021) Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. Respiratory Physiology & Neurobiology 283, pages 103548.
Crossref
Crossref
Anna Danilova, Vsevolod Misyurin, Aleksei Novik, Dmitry Girdyuk, Natalia Avdonkina, Tatiana Nekhaeva, Natalia Emelyanova, Nino Pipia, Andrey Misyurin & Irina Baldueva. (2020) Cancer/testis antigens expression during cultivation of melanoma and soft tissue sarcoma cells. Clinical Sarcoma Research 10:1.
Crossref
Crossref
Inken Salewski, Yvonne Saara Gladbach, Steffen Kuntoff, Nina Irmscher, Olga Hahn, Christian Junghanss & Claudia Maletzki. (2020) In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters. Journal of Translational Medicine 18:1.
Crossref
Crossref
Michael-Joseph Gorbet & Ashish Ranjan. (2020) Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy. Pharmacology & Therapeutics 207, pages 107456.
Crossref
Crossref
Anna Shangguan, Na Shang, Matteo Figini, Liang Pan, Jia Yang, Quanhong Ma, Su Hu, Aydin Eresen, Chong Sun, Bin Wang, Yuri Velichko, Vahid Yaghmai & Zhuoli Zhang. (2020) Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. Cytotherapy 22:1, pages 6-15.
Crossref
Crossref
Saraswoti Khadge, John Graham Sharp, Geoffrey M. Thiele, Timothy R. McGuire & James E. Talmadge. 2020. Tumor Microenvironment. Tumor Microenvironment
125
153
.
Zhixiong Cai, Fuli Xin, Zuwu Wei, Ming Wu, Xinyi Lin, Xiaofan Du, Geng Chen, Da Zhang, Zhenxi Zhang, Xiaolong Liu & Cuiping Yao. (2019) Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal–Organic Framework Nanoparticles to Boost Cancer Immunotherapy. Advanced Healthcare Materials 9:1, pages 1900996.
Crossref
Crossref
Liangrong Shi, Junjun Wang, Nianhua Ding, Yi Zhang, Yibei Zhu, Shunli Dong, Xiaohui Wang, Changli Peng, Chunhui Zhou, Ledu Zhou, Xiaodong Li, Hongbing Shi, Wei Wu, Xueyin Long, Changping Wu & Weihua Liao. (2019) Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy. Nature Communications 10:1.
Crossref
Crossref
Polina Weitzenfeld, Stylianos Bournazos & Jeffrey V. Ravetch. (2019) Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways. Journal of Clinical Investigation 129:9, pages 3952-3962.
Crossref
Crossref
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
45
59
.
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy
19
44
.
Saraswoti Khadge, John Graham Sharp, Timothy R. McGuire, Geoffrey M. Thiele, Paul Black, Concetta DiRusso, Leah Cook, Lynell W. Klassen & James E. Talmadge. (2018) Immune regulation and anti-cancer activity by lipid inflammatory mediators. International Immunopharmacology 65, pages 580-592.
Crossref
Crossref
Victor I. Seledtsov & Galina V. Seledtsova. (2018) Attaining threshold antibody cytotoxicity for selective tumor cell destruction: an opinion article. Oncotarget 9:87, pages 35790-35794.
Crossref
Crossref
CHARLOTTE DE Wolf, MARJA VAN DE BOVENKAMP & MARCEL HOEFNAGEL. (2018) Regulatory perspective on in vitro potency assays for human dendritic cells used in anti-tumor immunotherapy. Cytotherapy 20:11, pages 1289-1308.
Crossref
Crossref
Kosei Hasegawa, Yuji Ikeda, Yuko Kunugi, Akira Kurosaki, Yuichi Imai, Shunsuke Kohyama, Shoji Nagao, Eito Kozawa, Koji Yoshida, Takuya Tsunoda, Yusuke Nakamura & Keiichi Fujiwara. (2018) Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer. Journal of Immunotherapy 41:4, pages 201-207.
Crossref
Crossref
Charlotte de Wolf, Marja van de Bovenkamp & Marcel Hoefnagel. (2018) Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy. Cytotherapy 20:5, pages 601-622.
Crossref
Crossref
Rajendran JC Bose, Ramasamy Paulmurugan, James Moon, Soo-Hong Lee & Hansoo Park. (2018) Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics. Drug Discovery Today 23:4, pages 891-899.
Crossref
Crossref
Felix S. Lichtenegger, Maurine Rothe, Frauke M. Schnorfeil, Katrin Deiser, Christina Krupka, Christian Augsberger, Miriam Schlüter, Julia Neitz & Marion Subklewe. (2018) Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells. Frontiers in Immunology 9.
Crossref
Crossref
Benjamin Frey, Michael Rückert, Lisa Deloch, Paul F. Rühle, Anja Derer, Rainer Fietkau & Udo S. Gaipl. (2017) Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases. Immunological Reviews 280:1, pages 231-248.
Crossref
Crossref
Mohamed L. Salem, Mohamed Nassef, Soha Gomaa & Ibrahim Essa. (2017) Synergistic combination of murine bone marrow-derived dendritic cells loaded ex vivo with whole tumor lysate and systemic chemotherapy mediates antitumor immune responses in vivo. Biomedicine & Pharmacotherapy 93, pages 286-295.
Crossref
Crossref
Hee Kap Kang, Shusen Wang, Anil Dangi, Xiaomin Zhang, Amar Singh, Lei Zhang, James M. Rosati, Wilma Suarez-Pinzon, Xuelian Deng, Xiaoyan Chen, Edward B. Thorp, Bernhard J. Hering, Stephen D. Miller & Xunrong Luo. (2017) Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice. Transplantation 101:8, pages 1801-1810.
Crossref
Crossref
Monika Barełkowska & Katarzyna Derwich. 2017. Unique Aspects of Anti-cancer Drug Development. Unique Aspects of Anti-cancer Drug Development.
Junko Masuda, Eiji Takayama, Warren Strober, Ayano Satoh, Yuji Morimoto, Yasuko Honjo, Tatsuo Ichinohe, Shin-Ichi Tokuno, Toshiaki Ishizuka, Takahiro Nakata, Akifumi Mizutani, Naoki Umemura, Atsushi Kitani, Ivan Fuss, Tsukasa Shigehiro, Harumi Kawaki, Masako Mizuno-kamiya, Nobuo Kondoh & Masaharu Seno. (2017) Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities. Oncology Reports.
Crossref
Crossref
Victor I. Seledtsov & Galina V. Seledtsova. (2017) A Possible Role for Idiotype/Anti-idiotype B–T Cell Interactions in Maintaining Immune Memory. Frontiers in Immunology 8.
Crossref
Crossref
Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin & Qi-Jun Qian. (2017)
Mesothelin-targeting chimeric antigen receptor–modified T cells by
piggyBac
transposon system suppress the growth of bile duct carcinoma
. Tumor Biology 39:4, pages 101042831769594.
Crossref
Crossref
Kamel Ait-Tahar, Amanda P. Anderson, Martin Barnardo, Graham P. Collins, Chris S. R. Hatton, Alison H. Banham & Karen Pulford. (2017) Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients. Advances in Hematology 2017, pages 1-9.
Crossref
Crossref
George A. Parker & Tracey L. Papenfuss. 2017. Immunopathology in Toxicology and Drug Development. Immunopathology in Toxicology and Drug Development
1
93
.
Guodong Deng, Pingping Hu, Jingxin Zhang, Qiqi Liu, Ning Liang, Jian Xie, Lili Qiao, Hui Luo, Deguo Xu, Fengjun Liu, Xinshuang Yu, Zhen liu, Yajuan Lv & Jiandong Zhang. (2016) Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer. Oncotarget 7:51, pages 85142-85150.
Crossref
Crossref
Kyoung-Ho Pyo, You-Won Lee, Sun Min Lim & Eun-Hee Shin. (2016)
Immune adjuvant effect of a
Toxoplasma gondii
profilin-like protein in autologous whole-tumor-cell vaccination in mice
. Oncotarget 7:45, pages 74107-74119.
Crossref
Crossref
Roni Engelstein, Sharon Merims, Galit Eisenberg, Jonathan Cohen, Stephen Frank, Tamar Hamburger, Shoshana Frankenburg, Ilan Ron, Ruth Isacson, Tal Grenader, Hanna Steinberg, Cyrille J. Cohen, Tamar Peretz & Michal Lotem. (2016) Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBL. Journal of Immunotherapy 39:8, pages 321-328.
Crossref
Crossref
XueZhi Yang, Yan Chang & Wei Wei. (2016) Endothelial Dysfunction and Inflammation: Immunity in Rheumatoid Arthritis. Mediators of Inflammation 2016, pages 1-9.
Crossref
Crossref
V.I. Seledtsov, A.G. Goncharov & G.V Seledtsova. (2015) Multiple-purpose immunotherapy for cancer. Biomedicine & Pharmacotherapy 76, pages 24-29.
Crossref
Crossref
Jacob Freedman, Henrik Nilsson & Eduard Jonas. (2015) New horizons in ablation therapy for hepatocellular carcinoma. Hepatic Oncology 2:4, pages 349-358.
Crossref
Crossref